Clinical Trial Update: Efficacy, Safety, Tolerability, and Pharmacokinetics of Sotrastaurin Combined With Tacrolimus vs. a Mycophenolic Acid-tacrolimus Regimen in Renal Transplant Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing sotrastaurin plus tacrolimus versus mycophenolic acid-tacrolimus in renal transplant patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplantation

Drugs mentioned

• Mycophenolic acid (mycophenolic acid)
• Sotrastaurin
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Renal Transplantation | Phase 2 | Status: COMPLETED